$NORD
Nordicus Partners Corp

2023 Q3 Form 10-K Financial Statement

#000149315223024627 Filed on July 14, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2023 Q1 2023
Revenue $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $96.88K $2.539M
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $96.88K $2.539M $8.480M
YoY Change 106.13% 4690.36% 2644.3%
Operating Profit -$96.88K -$8.480M
YoY Change 106.13% 2642.78%
Interest Expense -$380.00 $382.00
YoY Change
% of Operating Profit
Other Income/Expense, Net -$1.909K $60.00 $7.673K
YoY Change -65.12%
Pretax Income -$98.79K -$2.539M -$8.472M
YoY Change 110.19% 4690.98% 2851.99%
Income Tax
% Of Pretax Income
Net Earnings -$98.79K -$2.539M -$8.472M
YoY Change 110.19% 4690.98% 2851.99%
Net Earnings / Revenue
Basic Earnings Per Share -$0.01 -$1.43
Diluted Earnings Per Share -$0.01 -$0.38 -$1.43
COMMON SHARES
Basic Shares Outstanding 10.80M shares 5.681M shares 5.939M shares
Diluted Shares Outstanding 10.85M shares 5.939M shares

Balance Sheet

Concept 2023 Q3 2023 Q1 2023
SHORT-TERM ASSETS
Cash & Short-Term Investments $10.77K $7.150K $7.150K
YoY Change 977.0% -97.09% -97.09%
Cash & Equivalents $10.77K $7.149K
Short-Term Investments
Other Short-Term Assets $0.00 $770.00 $770.00
YoY Change -100.0% -80.75% -80.75%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $10.77K $52.40K $52.40K
YoY Change 7.72% -79.04% -79.04%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $1.750M
YoY Change
Other Assets $5.327K $2.625K
YoY Change
Total Long-Term Assets $1.755M $2.625K $2.630K
YoY Change
TOTAL ASSETS
Total Short-Term Assets $10.77K $52.40K $52.40K
Total Long-Term Assets $1.755M $2.625K $2.630K
Total Assets $1.766M $55.03K $55.03K
YoY Change 17560.99% -77.99% -77.99%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $9.880K $13.48K $13.48K
YoY Change -55.09% -68.65% -68.65%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $25.69K $27.37K $27.37K
YoY Change -8.24% -50.24% -50.24%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $25.69K $27.37K $27.37K
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $25.69K $27.37K $27.37K
YoY Change -8.24% -50.24% -50.24%
SHAREHOLDERS EQUITY
Retained Earnings -$42.34M -$42.20M
YoY Change 9.1% 25.12%
Common Stock $10.88K $8.296K
YoY Change 81.27% 38.27%
Preferred Stock
YoY Change
Treasury Stock (at cost) $30.33K $30.33K
YoY Change 1.09% 1.09%
Treasury Stock Shares
Shareholders Equity $1.740M $27.66K $27.66K
YoY Change
Total Liabilities & Shareholders Equity $1.766M $55.03K $55.03K
YoY Change 17560.99% -77.99% -77.99%

Cashflow Statement

Concept 2023 Q3 2023 Q1 2023
OPERATING ACTIVITIES
Net Income -$98.79K -$2.539M -$8.472M
YoY Change 110.19% 4690.98% 2851.99%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$100.1K -$228.4K -$368.3K
YoY Change 127.48% 200.46% 30.62%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $0.00
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 81.92K 229.9K $128.9K
YoY Change -158.1% 14.95% -67.78%
NET CHANGE
Cash From Operating Activities -100.1K -228.4K -$368.3K
Cash From Investing Activities
Cash From Financing Activities 81.92K 229.9K $128.9K
Net Change In Cash -18.17K 1.540K -$239.5K
YoY Change -90.18% -98.76% -302.93%
FREE CASH FLOW
Cash From Operating Activities -$100.1K -$228.4K -$368.3K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022 us-gaap Interest Paid Net
InterestPaidNet
usd
CY2023 dei Entity Central Index Key
EntityCentralIndexKey
0001011060
CY2023 dei Amendment Flag
AmendmentFlag
false
CY2023 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2022Q1 us-gaap Receivables Net Current
ReceivablesNetCurrent
usd
CY2022Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
usd
CY2023Q1 us-gaap Accounts Payable Related And Nonrelated Party Status Extensible Enumeration
AccountsPayableRelatedAndNonrelatedPartyStatusExtensibleEnumeration
http://fasb.org/us-gaap/2023#RelatedPartyMember
CY2022Q1 us-gaap Accounts Payable Related And Nonrelated Party Status Extensible Enumeration
AccountsPayableRelatedAndNonrelatedPartyStatusExtensibleEnumeration
http://fasb.org/us-gaap/2023#RelatedPartyMember
CY2022Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
usd
CY2023Q1 us-gaap Other Liability Current Related And Nonrelated Party Status Extensible Enumeration
OtherLiabilityCurrentRelatedAndNonrelatedPartyStatusExtensibleEnumeration
http://fasb.org/us-gaap/2023#RelatedPartyMember
CY2022Q1 us-gaap Other Liability Current Related And Nonrelated Party Status Extensible Enumeration
OtherLiabilityCurrentRelatedAndNonrelatedPartyStatusExtensibleEnumeration
http://fasb.org/us-gaap/2023#RelatedPartyMember
CY2023Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q1 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2022Q1 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2022Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
usd
CY2022 us-gaap Interest Expense
InterestExpense
usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2022 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
usd
CY2022 NORD Stock Based Compensation Related Party
StockBasedCompensationRelatedParty
usd
CY2022 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
usd
CY2022 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
usd
CY2022 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
usd
CY2022 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
usd
CY2023 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
usd
CY2022 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
usd
CY2023 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
CY2022 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
CY2023 us-gaap Interest Paid Net
InterestPaidNet
usd
CY2023Q1 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
usd
CY2022Q1 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
usd
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2023 dei Document Type
DocumentType
10-K
CY2023 dei Document Annual Report
DocumentAnnualReport
true
CY2023 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--03-31
CY2023 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023 dei Document Transition Report
DocumentTransitionReport
false
CY2023 dei Entity File Number
EntityFileNumber
0-28034
CY2023 dei Entity Registrant Name
EntityRegistrantName
NORDICUS PARTNERS CORPORATION
CY2023 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2023 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
04-3186647
CY2023 dei Entity Address Address Line1
EntityAddressAddressLine1
3651 Lindell Road
CY2023 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite D565
CY2023 dei Entity Address City Or Town
EntityAddressCityOrTown
Las Vegas
CY2023 dei Entity Address State Or Province
EntityAddressStateOrProvince
NV
CY2023 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
89103
CY2023 dei City Area Code
CityAreaCode
(424)
CY2023 dei Local Phone Number
LocalPhoneNumber
256-8560
CY2023 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2023 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2023 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023 dei Entity Small Business
EntitySmallBusiness
true
CY2023 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023 dei Document Fin Stmt Error Correction Flag
DocumentFinStmtErrorCorrectionFlag
false
CY2023 dei Entity Shell Company
EntityShellCompany
false
CY2022Q3 dei Entity Public Float
EntityPublicFloat
646121 usd
CY2023Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
10796248 shares
CY2023 dei Auditor Firm
AuditorFirmId
5525
CY2022 dei Auditor Firm
AuditorFirmId
287
CY2023 dei Auditor Name
AuditorName
Fruci & Associates II, PLLC
CY2023 dei Auditor Location
AuditorLocation
Spokane, Washington
CY2022 dei Auditor Name
AuditorName
Liggett & Webb, P.A.
CY2022 dei Auditor Location
AuditorLocation
Boynton Beach, Florida
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
7149 usd
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
245945 usd
CY2023Q1 us-gaap Receivables Net Current
ReceivablesNetCurrent
44481 usd
CY2023Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
770 usd
CY2022Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3500 usd
CY2023Q1 us-gaap Assets Current
AssetsCurrent
52400 usd
CY2022Q1 us-gaap Assets Current
AssetsCurrent
249445 usd
CY2023Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2625 usd
CY2023Q1 us-gaap Assets
Assets
55025 usd
CY2022Q1 us-gaap Assets
Assets
249445 usd
CY2023Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
1354 usd
CY2022Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
43422 usd
CY2023Q1 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
12127 usd
CY2022Q1 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
11512 usd
CY2023Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
13886 usd
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
27367 usd
CY2022Q1 us-gaap Liabilities Current
LiabilitiesCurrent
54934 usd
CY2023Q1 us-gaap Liabilities
Liabilities
27367 usd
CY2022Q1 us-gaap Liabilities
Liabilities
54934 usd
CY2023Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2022Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2023Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2022Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
8296248 shares
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
5682782 shares
CY2022Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
8299276 shares
CY2022Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
5681248 shares
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
8296 usd
CY2022Q1 us-gaap Common Stock Value
CommonStockValue
5681 usd
CY2023Q1 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
1534 shares
CY2022Q1 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
1534 shares
CY2023Q1 us-gaap Treasury Stock Value
TreasuryStockValue
30328 usd
CY2022Q1 us-gaap Treasury Stock Value
TreasuryStockValue
30328 usd
CY2023Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
42246688 usd
CY2022Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
33944605 usd
CY2023Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
665 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-42197663 usd
CY2022Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-33725447 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
27658 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
194511 usd
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
55025 usd
CY2022Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
249445 usd
CY2023 us-gaap Share Based Compensation
ShareBasedCompensation
8141501 usd
CY2023 us-gaap Professional Fees
ProfessionalFees
102286 usd
CY2022 us-gaap Professional Fees
ProfessionalFees
119863 usd
CY2023 NORD Consulting Expense
ConsultingExpense
39602 usd
CY2022 NORD Consulting Expense
ConsultingExpense
105565 usd
CY2023 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
196500 usd
CY2022 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
83743 usd
CY2023 us-gaap Operating Expenses
OperatingExpenses
8479889 usd
CY2022 us-gaap Operating Expenses
OperatingExpenses
309171 usd
CY2023 us-gaap Operating Income Loss
OperatingIncomeLoss
-8479889 usd
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-309171 usd
CY2023 us-gaap Interest Expense
InterestExpense
382 usd
CY2023 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
8055 usd
CY2022 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
22000 usd
CY2023 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
7673 usd
CY2022 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
22000 usd
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-8472216 usd
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-287171 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-8472216 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-287171 usd
CY2023 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
665 usd
CY2023 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-8471551 usd
CY2022 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-287171 usd
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.43
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.30
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5938851 shares
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
944651 shares
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
81682 usd
CY2022 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
400000 usd
CY2022 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-287171 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
194511 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
194511 usd
CY2023 NORD Adjustments To Additional Paid In Capital Stockbased Compensation Fair Value Of Warrants
AdjustmentsToAdditionalPaidInCapitalStockbasedCompensationFairValueOfWarrants
8141501 usd
CY2023 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
48197 usd
CY2023 NORD Stock Issued During Period Value Exercise Of Warrants
StockIssuedDuringPeriodValueExerciseOfWarrants
115000 usd
CY2023 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-8471551 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
27658 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
27658 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-8472216 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-287171 usd
CY2023 NORD Stock Based Compensation Related Party
StockBasedCompensationRelatedParty
8141501 usd
CY2023 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-3500 usd
CY2022 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
3500 usd
CY2023 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-41132 usd
CY2022 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
8290 usd
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-368347 usd
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-282381 usd
CY2023 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
40000 usd
CY2023 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
40000 usd
CY2023 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
115000 usd
CY2023 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
13886 usd
CY2022 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
400000 usd
CY2023 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
128886 usd
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
400000 usd
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-239461 usd
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
117619 usd
CY2023 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
665 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
245945 usd
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
128326 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
7149 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
245945 usd
CY2023 us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_84C_eus-gaap--UseOfEstimates_zKNwhJd5HFz3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_861_zapUvsGOdgwk">Use of Estimates</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. The Company’s accounting estimates include the collectability of receivables, useful lives of long-lived assets and recoverability of those assets, impairment in fair value of goodwill.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p id="xdx_84A_eus-gaap--ConcentrationRiskCreditRisk_zvT90vh0evD" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_86A_zS8DlDjLw138">Concentration of Credit Risk</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We maintain our cash in bank deposit accounts, the balances of which at times may exceed federally insured limits. We continually monitor our banking relationships and consequently have not experienced any losses in our accounts. We believe we are not exposed to any significant credit risk on cash.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q1 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0 usd
CY2022Q1 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0 usd
CY2023 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
6635000 shares
CY2022 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0 shares
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-42197663 usd
CY2023Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2023Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023 NORD Preferred Stock Issued And Redeemed Shares
PreferredStockIssuedAndRedeemedShares
500000 shares
CY2022Q3 us-gaap Payments Of Capital Distribution
PaymentsOfCapitalDistribution
141000 usd
CY2022Q3 us-gaap Share Price
SharePrice
0.25
CY2023 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
825000 usd
CY2023 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2023 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210 pure
CY2022 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210 pure
CY2023 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.063 pure
CY2022 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.063 pure
CY2023 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
0.000 pure
CY2022 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
0.000 pure
CY2023 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0.000 pure
CY2022 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0.000 pure
CY2023 NORD Effective Income Tax Rate Reconciliation Other Adjustments Utilization Of Net Operating Losses
EffectiveIncomeTaxRateReconciliationOtherAdjustmentsUtilizationOfNetOperatingLosses
-0.273 pure
CY2022 NORD Effective Income Tax Rate Reconciliation Other Adjustments Utilization Of Net Operating Losses
EffectiveIncomeTaxRateReconciliationOtherAdjustmentsUtilizationOfNetOperatingLosses
-0.273 pure
CY2023 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.000 pure
CY2022 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.000 pure
CY2023Q1 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
2313000000 usd
CY2022Q1 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
3183000 usd
CY2023Q1 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
2313000000 usd
CY2022Q1 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
3183000 usd

Files In Submission

Name View Source Status
0001493152-23-024627-index-headers.html Edgar Link pending
0001493152-23-024627-index.html Edgar Link pending
0001493152-23-024627.txt Edgar Link pending
0001493152-23-024627-xbrl.zip Edgar Link pending
aud_001.jpg Edgar Link pending
aud_002.jpg Edgar Link pending
ex3-1.htm Edgar Link pending
ex3-1_001.jpg Edgar Link pending
ex3-1_002.jpg Edgar Link pending
ex3-1_003.jpg Edgar Link pending
ex3-1_004.jpg Edgar Link pending
ex3-1_005.jpg Edgar Link pending
ex3-1_006.jpg Edgar Link pending
ex3-1_007.jpg Edgar Link pending
ex3-1_008.jpg Edgar Link pending
ex3-1_009.jpg Edgar Link pending
ex3-1_010.jpg Edgar Link pending
ex3-1_011.jpg Edgar Link pending
ex3-1_012.jpg Edgar Link pending
ex3-1_013.jpg Edgar Link pending
ex3-1_014.jpg Edgar Link pending
ex3-1_015.jpg Edgar Link pending
ex3-1_016.jpg Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-k.htm Edgar Link pending
MetaLinks.json Edgar Link pending
nord-20230331.xsd Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
nord-20230331_cal.xml Edgar Link unprocessable
nord-20230331_def.xml Edgar Link unprocessable
nord-20230331_lab.xml Edgar Link unprocessable
nord-20230331_pre.xml Edgar Link unprocessable
form10-k_htm.xml Edgar Link completed
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable